Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
129,821,091
-
Total 13F shares
-
34,704,785
-
Share change
-
-13,210,914
-
Total reported value
-
$20,548,206
-
Put/Call ratio
-
0%
-
Price per share
-
$0.59
-
Number of holders
-
50
-
Value change
-
-$8,230,895
-
Number of buys
-
30
-
Number of sells
-
49
Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q2 2025
As of 30 Jun 2025,
PROKIDNEY CORP. - Ordinary Shares (PROK) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,704,785 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Bleichroeder LP, BlackRock, Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Brown University, Hennion & Walsh Asset Management, Inc., and BANK OF AMERICA CORP /DE/.
This page lists
50
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.